These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 20721819)
21. Application of fluorescence polarization in HTS assays. Huang X; Aulabaugh A Methods Mol Biol; 2009; 565():127-43. PubMed ID: 19551360 [TBL] [Abstract][Full Text] [Related]
22. High-throughput screening using beta-lactamase reporter-gene technology for identification of low-molecular-weight antagonists of the human gonadotropin releasing hormone receptor. Oosterom J; van Doornmalen EJ; Lobregt S; Blomenröhr M; Zaman GJ Assay Drug Dev Technol; 2005 Apr; 3(2):143-54. PubMed ID: 15871689 [TBL] [Abstract][Full Text] [Related]
23. American association for cancer research - 101st annual meeting - investigating new therapeutic candidates: part 2. Mason VL IDrugs; 2010 Jun; 13(6):360-2. PubMed ID: 20506053 [TBL] [Abstract][Full Text] [Related]
24. 3D inverted colloidal crystals in realistic cell migration assays for drug screening applications. da Silva J; Lautenschläger F; Kuo CH; Guck J; Sivaniah E Integr Biol (Camb); 2011 Dec; 3(12):1202-6. PubMed ID: 22038190 [TBL] [Abstract][Full Text] [Related]
25. Impact of new technologies for cellular screening along the drug value chain. Möller C; Slack M Drug Discov Today; 2010 May; 15(9-10):384-90. PubMed ID: 20206290 [TBL] [Abstract][Full Text] [Related]
26. High-Content Analysis--CHI's Seventh Annual Conference--Flow Cytometry in Drug Discovery and Development. Robinson JP IDrugs; 2010 Mar; 13(3):153-5. PubMed ID: 20191428 [TBL] [Abstract][Full Text] [Related]
35. Drug and bioactive molecule screening based on a bioelectrical impedance cell culture platform. Ramasamy S; Bennet D; Kim S Int J Nanomedicine; 2014; 9():5789-809. PubMed ID: 25525360 [TBL] [Abstract][Full Text] [Related]
36. Screening for content--the evolution of high throughput. Dove A Nat Biotechnol; 2003 Aug; 21(8):859-64. PubMed ID: 12894197 [No Abstract] [Full Text] [Related]
37. The evolution of microarrayed compound screening. Hoever M; Zbinden P Drug Discov Today; 2004 Apr; 9(8):358-65. PubMed ID: 15081963 [TBL] [Abstract][Full Text] [Related]
38. American Society of Clinical Oncology--46th annual meeting. Al-Shamahi A; Murch L; Kirkham K IDrugs; 2010 Aug; 13(8):506-9. PubMed ID: 20721815 [TBL] [Abstract][Full Text] [Related]
39. An update of novel screening methods for GPCR in drug discovery. Chen L; Jin L; Zhou N Expert Opin Drug Discov; 2012 Sep; 7(9):791-806. PubMed ID: 22716301 [TBL] [Abstract][Full Text] [Related]
40. Targeted Cancer Therapies World Congress 2010--part 2. 21-23 September 2010, Zurich, Switzerland. Youssoufian H IDrugs; 2010 Dec; 13(12):833-5. PubMed ID: 21154137 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]